Mimura, Hidefumi
Akita, Sadanori
Fujino, Akihiro
Jinnin, Masatoshi
Ozaki, Mine
Osuga, Keigo
Nakaoka, Hiroki
Morii, Eiichi
Kuramochi, Akira
Aoki, Yoko
Arai, Yasunori
Aramaki, Noriko
Inoue, Masanori
Iwashina, Yuki
Iwanaka, Tadashi
Ueno, Shigeru
Umezawa, Akihiro
Ozeki, Michio
Ochi, Junko
Kinoshita, Yoshiaki
Kurita, Masakazu
Seike, Shien
Takakura, Nobuyuki
Takahashi, Masataka
Tachibana, Takao
Chuman, Kumiko
Nagata, Shuji
Narushima, Mitsunaga
Niimi, Yasunari
Nosaka, Shunsuke
Nozaki, Taiki
Hashimoto, Kazuki
Hayashi, Ayato
Hirakawa, Satoshi
Fujikawa, Atsuko
Hori, Yumiko
Matsuoka, Kentaro
Mori, Hideki
Yamamoto, Yuki
Yuzuriha, Shunsuke
Rikihisa, Naoaki
Watanabe, Shoji
Watanabe, Shinichi
Kuroda, Tatsuo
Sugawara, Shunsuke
Ishikawa, Kosuke
Sasaki, Satoru
Article History
First Online: 23 March 2020
Compliance with ethical standards
:
: Conflict of interest of the guidelines preparation organization was managed by the Guidelines Executive Committee. The following corporations were disclosed by self-declaration of the Guidelines Committee members in the 3 year-period before 1 April 2017. Japan Pharmaceuticals and Medical Devices Agency (PMDA), Mitsubishi Foundation, Rohto Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, and Shionogi & Co., Ltd.